While the impact of the COVID-19 pandemic continues to unfold, distributors are taking proactive steps and working closely with the broader healthcare community to respond to the crisis and prevent disruptions to the pharmaceutical supply chain. As the logistics experts of healthcare, our commitment is to ensure that providers, pharmacies and the patients they serve have access to the vital medicines and supplies they need during these challenging times.
As the impact of COVID-19 “coronavirus” pandemic continues to unfold, we are all deeply concerned about our personal health and well-being — and that of our loved ones. As Americans worry about when their workplaces or schools will reopen, or if they have an adequate supply of necessary household staples, many also have heightened concerns about whether they will be able to access the vital medications and healthcare products they rely on each day.
HDA has published “A Year in Review,” which chronicles the Alliance’s 2019 activities. Highlighted accomplishments include:
Most days, pharmaceutical distributors fulfill their vital role largely unnoticed. Patients take for granted their medications will reach them safely and quickly. They don’t think about the systems, protocols, professionalism and technology required to make delivery seamless from manufacturer to pharmacy and, ultimately, to them.